S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Procter & Gamble Faces Global Headwinds Ahead of Fiscal Q4 Results

Procter & Gamble prepares to report its fiscal fourth-quarter results Wednesday, facing a delicate balance between rising sales expectations and a cooling global consumer. Wall Street anticipates $21.38 billion in revenue, though persistent concerns over generic brand switching and economic volatility in China loom over the company’s outlook.

Procter & Gamble Faces Global Headwinds Ahead of Fiscal Q4 Results

Analysts polled by FactSet project the consumer giant will post a profit of $3.38 billion, down from $3.62 billion in the same period last year. Adjusted earnings per share are forecasted at $1.41, trailing the $1.48 recorded a year ago. Despite these pressures, P&G stock has climbed 7% this year, trading recently near $151.

Deutsche Bank researchers highlight the company as a key indicator of consumer health, noting that uneven global demand and geopolitical instability complicate the path forward. While U.S. spending showed signs of improvement in June, investors remain wary of the company’s reliance on promotional pricing to combat shoppers moving toward cheaper store-brand alternatives. Meanwhile, BNP Paribas analysts point to China—P&G’s second-largest market—as a significant risk factor, citing soft retail sales and stagnant demand. These results will update the market on how the manufacturer of Tide and Pampers is navigating the ongoing squeeze from commodity costs and trade tariffs.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!